IceCure Medical Ltd. announced an exclusive distribution agreement with Rise General Trading, LLC for IceCure's ProSense® Cryoablation System in the United Arab Emirates and Persian Gulf States ("the territories"). Under the terms of the agreement, Rise General Trading, LCC will purchase a minimum amount of approximately $16 million of IceCure's products over a period of three years. The first purchase order will be executed within three months after the receipt of all regulatory licenses necessary for the sale of IceCure's products in the first territory. Licenses required by Rise General Trading, LCC include licenses for the import, marketing, and sale of IceCure's products to the relevant territory. The product distribution will be overseen by the Rise Healthcare division, which manages a diversified portfolio of medical devices for Oncology, Pediatrics and Respiratory specialties.